Regulation News

Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.

FirstEnergy Ohio Rate Plan Could Add $5 to Monthly Bills
Regulation James Calloway

FirstEnergy Ohio Rate Plan Could Add $5 to Monthly Bills

FirstEnergy's Ohio utilities are set to file a three-year rate plan by May 22 that could raise typical residential bills by $4.26 to $5.30 per month annually.

FE
Skillz Stock Skyrockets After $420M False Advertising Win Over Papaya Gaming
Regulation James Calloway

Skillz Stock Skyrockets After $420M False Advertising Win Over Papaya Gaming

Skillz stock soared 187% after a jury ordered Papaya Gaming to pay $420 million for false advertising, with the possibility of an additional $652 million in disgorgement.

SKLZ
FirstEnergy Ohio Rate Plan to Raise Monthly Bills by Up to $5.30
Regulation James Calloway

FirstEnergy Ohio Rate Plan to Raise Monthly Bills by Up to $5.30

FirstEnergy's Ohio utilities plan to file a three-year rate proposal by May 22, aiming to fund $800M in annual grid improvements and $83M for tree trimming, which could increase monthly bills by $4.26-$5.30 for typical households.

FE
Super Micro Faces May 26 Deadline as Legal and Regulatory Woes Loom
Regulation James Calloway

Super Micro Faces May 26 Deadline as Legal and Regulatory Woes Loom

Super Micro Computer faces a May 26 lead plaintiff deadline in a securities lawsuit over undisclosed China sales and export-control lapses. The stock rose 2.7% but remains under pressure from criminal charges and regulatory uncertainty.

SMCI DELL NVDA
Capital One $425M Savings Account Settlement Cleared for Payout
Regulation James Calloway

Capital One $425M Savings Account Settlement Cleared for Payout

A federal judge granted final approval to Capital One's $425 million settlement regarding its 360 Savings accounts. Eligible customers from September 2019 through June 2025 could receive payments beginning July 21, barring any appeals.

COF
WBD Shareholders Vote on $110B Paramount Merger Amid Regulatory Scrutiny
Regulation James Calloway

WBD Shareholders Vote on $110B Paramount Merger Amid Regulatory Scrutiny

Warner Bros. Discovery investors are voting on a $110 billion takeover by Paramount Skydance, with shares trading 12% below the offer price. Regulatory reviews and industry opposition create significant hurdles for the deal.

WBD NFLX DIS
White House Considers $500M Lifeline for Spirit Airlines Amid Fuel Crisis
Regulation James Calloway

White House Considers $500M Lifeline for Spirit Airlines Amid Fuel Crisis

The White House is nearing a $500 million loan agreement for Spirit Airlines, which faces collapse due to soaring fuel prices. The administration also opposes a potential merger between United and American Airlines.

AAL UAL JBLU USO
Plug Power Faces Investor Lawsuit Proceeding Amid Louisiana Plant Showcase
Regulation James Calloway

Plug Power Faces Investor Lawsuit Proceeding Amid Louisiana Plant Showcase

A Delaware federal judge ruled that investors can advance claims against Plug Power regarding its hydrogen production targets and revenue forecasts. The decision coincided with a company-hosted tour of its key Louisiana plant, with shares declining roughly 5%.

PLUG
Psyence Biomedical Stock Surges on White House Psychedelic Research Push
Regulation James Calloway

Psyence Biomedical Stock Surges on White House Psychedelic Research Push

Psyence Biomedical's stock rose sharply following a White House executive order aimed at fast-tracking research into psychedelic therapies like ibogaine, though the company's lead drug remains in mid-stage trials.

PBM
FDA Peptide Review Sparks Rally for Hims & Hers Health
Regulation James Calloway

FDA Peptide Review Sparks Rally for Hims & Hers Health

Shares of Hims & Hers Health climbed sharply after regulators signaled a review of peptide restrictions, a development analysts view as a positive shift for the company's growth strategy.

HIMS
Hims & Hers Stock Jumps on FDA's Peptide Policy Review
Regulation James Calloway

Hims & Hers Stock Jumps on FDA's Peptide Policy Review

Shares of Hims & Hers Health climbed sharply after the U.S. Food and Drug Administration said it will reconsider regulations on certain peptides. The company, which acquired a peptide facility last year, sees this as an opportunity to expand beyond the GLP-1 market.

HIMS
Super Micro Board Probe into China Server Diversion Tests Investor Confidence
Regulation James Calloway

Super Micro Board Probe into China Server Diversion Tests Investor Confidence

Super Micro Computer is under a board-driven investigation into claims servers were diverted to China, as U.S. prosecutors allege former associates funneled $2.5B in AI technology. Shareholders will vote on directors at an April 15 meeting.

SMCI NVDA DELL HPE FXI